CEDAR KNOLLS, N.J.,
Jan. 30, 2020 /PRNewswire/ -- MYOS
RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a
bionutrition company and the owner of
Fortetropin®, a proprietary bioactive composition
made from fertilized egg yolk that helps build lean muscle,
announced today that it has entered into a distribution agreement
with Chewy (www.chewy.com), a leading online retailer of pet
food and pet-related products. Chewy will distribute MYOS
Canine Muscle Formula®, an advanced nutrition
product that has been clinically shown to increase muscle mass,
prevent atrophy of disuse and improve recovery from injuries in
canines. This study was conducted at Kansas
State University involving 100 dogs.
![](https://mma.prnewswire.com/media/1083932/MYOS_Canine_Muscle_Formula.jpg)
"We are delighted to be partnering with Chewy to distribute
MYOS Canine Muscle Formula to pet owners across the United States," stated Joseph Mannello, CEO, MYOS RENS
Technology. "Chewy is a leading online retailer of pet food
and pet-related products in the U.S. They distribute products of
the highest quality and provide outstanding customer service.
We feel honored that MYOS Canine Muscle Formula will be distributed
alongside leading brands in the pet food and pet nutrition market,"
added Mr. Mannello.
In 2019, MYOS announced at the North American Veterinary
Conference in Orlando, FL that
dogs that consumed MYOS Canine Muscle Formula following tibial
plateau leveling osteotomy (TPLO) surgery to repair tears of the
cranial cruciate ligament (CCL), experienced reduced muscle atrophy
and improved recovery after 8 weeks following surgery when compared
with dogs that received a macronutrient-matched placebo.
Following the announcement of results from this study, MYOS
announced the initiation of another clinical study at Kansas State University to examine the impact of
MYOS Canine Muscle Formula on quality of life and activity in
geriatric dogs.
In addition to the Company's distribution partnership with
Chewy, its products for the Canine Health Market are available
direct-to-consumer at www.myospet.com and at Amazon.com.
About MYOS RENS Technology Inc.
MYOS RENS Technology
Inc. (MYOS), "The Muscle Company®", is a Cedar Knolls, NJ-based advanced nutrition
company that develops and markets products that improve muscle
health and performance. MYOS is the owner of
Fortetropin®, a fertilized egg yolk-based product
manufactured via a proprietary process to retain and optimize its
biological activity. Fortetropin has been clinically shown to
increase muscle size, lean body mass and reduce muscle atrophy.
MYOS believes Fortetropin has the potential to redefine existing
standards of physical health and wellness. For more information,
please visit www.myosrens.com.
About Myos Canine Muscle Formula®
Myos
Canine Muscle Formula (Regular and Veterinarian Strength) is
an advanced veterinary health supplement to support muscle health
in dogs, featuring Fortetropin as the active ingredient.
Fortetropin is made through a patented process that maintains the
vital nutrients of fertilized egg yolks to help build more lean
muscle and decrease muscle loss. For more information, please
visit www.myospet.com.
Forward-Looking Statements
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products, including
MYOS Canine Muscle Formula®, Physician
Muscle Health Formula®,
Yolked®, Qurr® and
MYOS Enteral Nutrition Formula™, the success of
our research and development, the results of the clinical
evaluation of Fortetropin® and its
effects, the ability to enter into new partnership opportunities
and the success of our existing partnerships, the ability to
generate revenue and cash flow from sales of our products, the
ability to increase our revenue and gross profit margins, the
ability to achieve a sustainable, profitable business, the effect
of economic conditions, the ability to protect our intellectual
property rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in our filings with the Securities and Exchange
Commission. We undertake no obligation to update or revise any
forward-looking statement for events or circumstances after the
date on which such statement is made except as required by
law.
Investor Relations:
MYOS RENS Technology
Joanne Goodford
Phone: 973-509-0444
Email: jgoodford@myoscorp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-announces-distribution-partnership-for-their-blockbuster-canine-muscle-formula-with-chewy-a-leading-online-retailer-of-pet-food-and-pet-related-products-300995711.html
SOURCE MYOS RENS Technology